YES BANK Q2FY27 slides: profit surges 65% amid AT1 bond uncertainty

YES BANK reported Q2FY27 net profit of INR 1,080 crore, up 65% year over year, but the Supreme Court upheld the INR 8,415 crore AT1 bond write-down. The bank recognized no impact in reported results pending assessment; its pro forma estimates show a INR 5,217 crore loss and CET1 falling from 13.7% to 11.4%. Operating metrics improved, including NII growth of 22.7% and gross NPA improvement to 1.2%, while management expects Q3 NIM near 2.6% and cited the ruling as a major capital-planning uncertainty.

Analysis

The key market question is not whether YES BANK’s operating trend improved, but who bears the cost if the AT1 judgment changes accounting or regulatory capital treatment. The bank’s pro forma loss and lower CET1 are not recognized in Q2, and the final treatment remains unresolved; investors should not treat either the reported profit or the pro forma case as a settled run rate. Near term, that uncertainty can overwhelm improving asset quality and fee growth. Over 1–3 months, the catalysts are the bank’s legal/accounting assessment and any RBI direction on capital buffers or growth. Over 6–18 months, SMFG’s strategic sponsorship could help franchise credibility and corporate access, but any expectation of capital support is unverified and should not be priced as a commitment.

The less obvious operating risk is funding quality: headline deposit growth includes FCNR mobilization while CASA fell and deposit costs rose; that combination can constrain margins even if loan growth stays strong. If funding competition persists, balance-sheet expansion may translate into less earnings leverage than the headline growth suggests. Conversely, a clear regulatory resolution without a capital raise would remove a major overhang. The cited rating upgrades do not, by themselves, establish a material revenue catalyst for Moody’s or S&P Global. For mapped equities, the exposure is indirect: SMFG has strategic and reputational linkage, while Carlyle’s reported stake sale argues against assuming ongoing exposure. No clean directional trade in these mapped names is justified absent position size, capital-support commitments, or evidence of material financial impact.

Key Decisions for Investors

• Avoid treating YES BANK’s reported quarterly profit as a normalized earnings signal until final AT1 accounting and regulatory treatment are disclosed; keep exposure on watch rather than buying the operating-growth narrative alone.
• For SMFG (NYSE: SMFG), do not initiate a short solely on this ruling: the direct financial exposure and any support obligation are not specified. Escalate to a trade review if SMFG discloses a capital commitment, impairment, or material governance intervention.
• Track YES BANK’s next disclosures for CET1 treatment, any capital-raising plan, CASA/deposit-cost direction, and NIM versus its Q3 outlook. A regulatory capital requirement or sustained deposit-cost pressure would weaken the recovery thesis; resolution without a capital action and stable margins would reduce the overhang.
• No trade in MCO or SPGI on the rating actions cited: the article gives no evidence that the upgrades materially change either agency’s revenue or earnings outlook.